Product Reviews
Categories
- Alternative Medicine
- Cancer
- Acute Promyelocytic Leukemia
- Anal Cancer
- Bladder Cancer
- Breast cancer
- Colorectal cancer
- Endometrial Cancer
- Esophageal Cancer
- Gallbladder cancer
- Gastric Cancer
- Glioblastma
- Head and Neck Cancer
- Liver Cancer
- Lung Cancer
- Lymphoma
- Melanoma
- Nasopharyngeal Cancer
- Non-Hodgkin's Disease
- Ovarian Cancer
- Pancreatic Cancer
- Prostate cancer
- Renal Cancer
- Thyroid Cancer
- Cardiovascular disease
- Central Nervous System
- Constipation
- Diabetes
- Fatty Liver
- Irritable Bowel Syndrome
- Longevity
- Motherhood
- Obesity
- Others
- Psoriasis
- Respiratory Disease
- Rheumatoid Arthritis
Archives
Category Archives: Cancer
Bevacizumab Beneficial in Newly Diagnosed Glioblastoma?
A large study of patients with newly diagnosed glioblastoma multiforme suggests that the addition of bevacizumab (Avastin) and irinotecan (Camptosar) to standard chemoradiation can extend survival (progression and overall survival) by 6 months. Bevacizumab (Avastin) is an inhibitor of vascular … Continue reading
Posted in Cancer, Glioblastma
Tagged Avastin, bevacizumab, camptosar, chemoradiation, glioblastoma multiforme, Irinotecan, progression-free survival, Survival, Temodar, temozolomide
Comments Off on Bevacizumab Beneficial in Newly Diagnosed Glioblastoma?
Afatinib Extend Time to Tumor Progression in Advanced Lung Cancer
Currently, no treatment exists for lung cancer patients with epidermal growth-factor receptor (EGFR) mutation who have failed tyrosine kinase inhibitors, getifinib (Iressa) or erlotinib (Tarceva). However, an investigational drug, afatinib (BIBW 2992), was recently found to increase progression-free survival and … Continue reading
Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer
Tagged Afatinib, epidermal growth-factor receptor, erlotinib, getifinib, Iressa, Lung Cancer, Non small cell lung cancer, NSCLC, platinum, progression-free survival, Tarceva, time to tumor progression, tumor shrinkage
Comments Off on Afatinib Extend Time to Tumor Progression in Advanced Lung Cancer
Aspirin Can Prevent From Several Common Cancers
If you are taking aspirin to prevent heart attack, you should be glad to know that you might also be protected from a variety of cancers. According to a new study published in Lancet, taking aspirin over a long period … Continue reading
Posted in Breast cancer, Cancer, Cardiovascular disease, Colorectal cancer, Esophageal Cancer, Heart attack, Lung Cancer, Nasopharyngeal Cancer, Prostate cancer, Small Cell Lung Cancer
Tagged Aspirin, Cancers, colorectal cancer, Esophageal Cancer, gastrointestinal cancers, Heart attack, Lung Cancer, Prostate cancer
Comments Off on Aspirin Can Prevent From Several Common Cancers
FDA Panel Supports the Use of Vandetanib in Medullary Thyroid Cancer
An FDA advisory committee reported that they supported the use of AstraZeneca’s vandetanib for the treatment of patients with medullary thyroid cancer (MTC). However, they also indicated the drug should be reserved for patients who are experiencing symptoms of their … Continue reading
Posted in Cancer, Thyroid Cancer
Tagged disease progression, Medullary Thyroid Cancer, vandetanib
Comments Off on FDA Panel Supports the Use of Vandetanib in Medullary Thyroid Cancer
Pertuzumab Plus Herceptin Shows Promise in Early Breast Cancer
Just after four cycles of neoadjuvant use, the combination of Roche’s pertuzumab, Herceptin (trastuzumab) and chemotherapy improved the rate of complete tumor disappearance by more than half compared to conventional therapy in patients with HER2-positive breast cancer. The results came … Continue reading
Posted in Breast cancer, Cancer
Tagged Breast cancer, HER2-positive, Herceptin, neoadjuvant, NEOSPHERE, Pertuzumab, Trastuzumab, tumor disappearance
Comments Off on Pertuzumab Plus Herceptin Shows Promise in Early Breast Cancer
FDA Approves the First Drug for Tuberous Sclerosis Tumors
Good news for patients with subependymal giant cell astrocytoma (SEGA). The US Food and Drug Administration (FDA) has granted the approval for everolimus (Afinitor, Novartis) as the first medication for children and adults with SEGA who require therapeutic intervention but … Continue reading
Posted in Cancer
Tagged Afinitor, Everolimus, subependymal giant cell astrocytoma, Tuberous Sclerosis Tumors, tumor, tumor shrinkage
Comments Off on FDA Approves the First Drug for Tuberous Sclerosis Tumors
Breast and Endometrial Cancer – Causes, Symptoms, Diagnosis, Prognosis and Hormonal Treatment
Breast Cancer Breast cancer is the most commonly diagnosed cancer in women and the second leading cause of cancer death in the United States. It is estimated that the lifetime risk of developing breast cancer is one in eight, with … Continue reading
Posted in Breast cancer, Cancer, Endometrial Cancer
Tagged anastrozole, Arimidex, Aromasin, aromatase inhibitors, AstraZeneca, Breast cancer, Causes, Depo-Provera, Diagnosis, Endometrial cancer, estrogen antagonist, estrogen receptor antagonist, exemestane, Fareston, Faslodex, Femara, fulvestrant, Gonadotropin-releasing hormone, goserelin, Her2, Hormonal treatment, letrozole, leuprorelin acetate, mammography, medroxyprogesterone, Megace, megestrol, Nolvadex, progestins, Prognosis, Selective Estrogen Receptors Modulator, SERMS, Symptoms, tamoxifen, toremifene, Viadur, Zoladex
1 Comment
Black Tea Can Prevent Lung Cancer?
Black tea prevents nonsmokers from having lung cancer while milk and dairy products help deter lung cancer in smokers, according to research presented at CHEST 2010: American College of Chest Physicians Annual Meeting. The researchers conducted interviews and analysis on … Continue reading
Posted in Cancer, Lung Cancer, Non Small Cell Lung Cancer, Small Cell Lung Cancer, Tea
Tagged Black Tea, Lung Cancer, Pu'erh tea
Comments Off on Black Tea Can Prevent Lung Cancer?
